The stock of Motif Bio PLC (LON:MTFB) hit a new 52-week low and has GBX 20.02 target or 9.00% below today’s GBX 22.00 share price. The 6 months bearish chart indicates high risk for the GBX 40.19 million company. The 1-year low was reported on Nov, 30 by Barchart.com. If the GBX 20.02 price target is reached, the company will be worth GBX 3.62 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 1.12% or GBX 0.25 on November 30, hitting GBX 22. About 979,482 shares traded hands or 2.29% up from the average. Motif Bio PLC (LON:MTFB) has declined 53.16% since April 29, 2016 and is downtrending. It has underperformed by 58.38% the S&P500.
Motif Bio PLC (LON:MTFB) Ratings Coverage
Out of 2 analysts covering Motif Bio Plc (LON:MTFB), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Motif Bio Plc has been the topic of 42 analyst reports since July 23, 2015 according to StockzIntelligence Inc. The stock of Motif Bio PLC (LON:MTFB) earned “Speculative Buy” rating by Beaufort Securities on Thursday, March 3. Northland Capital maintained it with “Buy” rating and GBX 140 target price in Tuesday, August 16 report. On Monday, November 21 the stock rating was maintained by Northland Capital with “Buy”. Northland Capital maintained Motif Bio PLC (LON:MTFB) on Monday, January 25 with “Buy” rating. The rating was maintained by Beaufort Securities with “Speculative Buy” on Monday, October 19. The stock has “Speculative Buy” rating given by Beaufort Securities on Friday, April 15. Beaufort Securities maintained the shares of MTFB in a report on Tuesday, March 15 with “Speculative Buy” rating. The company was maintained on Friday, August 26 by Northland Capital. On Wednesday, November 11 the stock rating was maintained by Northland Capital with “Buy”. The stock of Motif Bio PLC (LON:MTFB) has “Buy” rating given on Tuesday, October 13 by Northland Capital.
More recent Motif Bio PLC (LON:MTFB) news were published by: Streetinsider.com which released: “Motif Bio plc (MTFB) IPO Opens Lower” on November 18, 2016. Also Uk.Finance.Yahoo.com published the news titled: “Motif Bio Plc (MTFB.L)” on April 02, 2015. Reuters.com‘s news article titled: “BRIEF-Motif Bio Plc’s ADS opens at $5.52 in US market debut” with publication date: November 18, 2016 was also an interesting one.
Motif Bio plc is a clinical-stage biopharmaceutical company. The company has a market cap of 40.19 million GBP. The Firm is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It currently has negative earnings. It operates in the development and commercialization of pharmaceutical formulations segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.